Ionis Share Price

Ionis Share Price

NASDAQ: IONS | Mid Cap | Healthcare
$27.81
+$0.89 (3.31%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Ionis Stock Performance

Open
$26.93
Prev. Close
$26.92
Circuit Range
N/A
Day Range
$26.87 - $28.00
Year Range
$26.57 - $86.71
Volume
1,21,352
Average Traded
$27.47

Ionis Share Price Today

As of 19 November 2026, Ionis Pharmaceuticals, Inc.'s share price is $27.81. The stock opened at $26.93, compared to its previous close of $26.92. During today's trading session, Ionis Pharmaceuticals, Inc.'s share price traded between $26.87 and $28.00, with an average price of $27.44. Over the past 52 weeks, the stock has recorded a high of $86.71 and a low of $26.57. In terms of performance, Ionis Pharmaceuticals, Inc.'s share price has declined by 63.64% over the last six months and is down 66.39% on a year-on-year basis.

Ionis Share Price Chart

Line chart of the Ionis price trend over the selected period. The price rose overall, ranging from 26.88 to 28.00, ending at 27.81.
$26.87$28.00
L
Show Current Price
H

Ionis Stock Fundamentals & Key Indicators

Market Cap
$4.45B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.28
Revenue (TTM)
$943.71B
Return On Equity (TTM)
-138.84%
Profit Margin
-40.41%
Debt to Equity
3.36
Quarterly Earnings Growth YoY
52.06%

Ionis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$203.33$246.09$267.95$242.72
Net Profit-$229.39-$92.53-$114.65-$109.97
Net Profit Margin-112.82%-37.60%-42.79%-45.31%
Income ChangeN/A59.66%-23.91%4.08%

Ionis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$587.37$787.65$705.14$943.71
Net Profit-$269.72-$366.29-$453.90-$381.39
Net Profit Margin-45.92%-46.50%-64.37%-40.41%
Income ChangeN/A-35.80%-23.92%15.97%

Ionis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets533.2383.39348.22331.18
Current Assets2990.642620.292641.852202.69
Total Assets3523.843003.682990.072533.88
Non Current Liabilities2253.182106.012155.31649.43
Current Liabilities781.57309.32448.09311.56
Total Liabilities3034.752415.322603.391960.99
Shareholders' Equity489.09588.35386.69572.89

Ionis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-268.58-500.95-307.51-274.37
Investing-277.78-134.03-214.13-262.64
Financing675.84478.06644.08-55.3

About Ionis

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).

Ionis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$43.91
$27.81
-36.14%
Oct 2026
$44.64
$43.55
-2.53%
Sep 2026
$60.84
$44.68
-28.45%
Aug 2026
$52.63
$62.45
+20.60%
Jul 2026
$79.20
$51.78
-34.74%
Jun 2026
$76.19
$79.34
+3.72%
May 2026
$75.16
$76.50
+2.28%
Apr 2026
$75.50
$74.79
-0.39%
Mar 2026
$79.44
$75.08
-7.45%
Feb 2026
$82.49
$81.12
-1.86%
Jan 2026
$78.99
$82.66
+4.43%
Dec 2025
$82.02
$79.15
-4.36%

Ionis Share Price FAQs